PRCT

MKT CAP:$1B

PROCEPT BioRobotics Corporation

Market Cap

$1B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$24.36-$6.40 (-20.81%)

Apr 24, 2026

Company Details

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive...

CEO

Larry L. Wood

IPO Date

Sep 15, 2021

Website

www.procept-biorobotics.com

Key Metrics TTM

Revenue

$308M

+37.2% YoY

Net Income

-$96M

EPS (Diluted)

-$1.72

Free Cash Flow

-$58M

Revenue / Share

$5.53

Gross Margin

63.7%

Operating Margin

-33.7%

Net Margin

-31.0%

FCF Margin

-18.9%

P/S

4.4x

P/E

—

Earnings Reports

FY 2025

Feb 26, 2026

$308M+37.2%EPS -$1.72

Q4 2025

Feb 26, 2026

$76M+11.9%EPS -$0.54

Q3 2025

Nov 5, 2025

$83M+42.8%EPS -$0.38

Q2 2025

Aug 7, 2025

$79M+48.4%EPS -$0.35

Q1 2025

May 2, 2025

$69M+55.3%EPS -$0.45

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$14M	$8M	-$16M
Q2 22	$17M	$8M	-$18M
Q3 22	$20M	$10M	-$22M
Q4 22	$24M	$11M	-$25M
Q1 23	$24M	$12M	-$28M
Q2 23	$33M	$18M	-$26M
Q3 23	$35M	$19M	-$26M
Q4 23	$44M	$21M	-$30M
Q1 24	$45M	$25M	-$28M
Q2 24	$53M	$31M	-$27M
Q3 24	$58M	$37M	-$22M
Q4 24	$68M	$44M	-$20M
Q1 25	$69M	$44M	-$27M
Q2 25	$79M	$52M	-$22M
Q3 25	$83M	$54M	-$23M
Q4 25	$76M	$46M	-$31M

Valuation

Quarter	P/S	P/E
Q1 22	34.0x	—
Q2 22	29.7x	—
Q3 22	30.9x	—
Q4 22	22.2x	—
Q1 23	16.8x	—
Q2 23	16.9x	—
Q3 23	13.8x	—
Q4 23	15.8x	—
Q1 24	15.3x	—
Q2 24	17.9x	—
Q3 24	20.7x	—
Q4 24	18.8x	—
Q1 25	12.2x	—
Q2 25	11.5x	—
Q3 25	6.7x	—
Q4 25	5.8x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$18M	-$18M
Q2 22	-$17M	-$17M
Q3 22	-$20M	-$21M
Q4 22	-$25M	-$26M
Q1 23	-$36M	-$41M
Q2 23	-$28M	-$34M
Q3 23	-$19M	-$25M
Q4 23	-$25M	-$34M
Q1 24	-$32M	-$34M
Q2 24	-$16M	-$17M
Q3 24	-$19M	-$19M
Q4 24	-$32M	-$34M
Q1 25	-$17M	-$19M
Q2 25	-$15M	-$18M
Q3 25	-$7M	-$10M
Q4 25	-$10M	-$12M

Capital Expenditures

Quarter	CapEx
Q1 22	$55.0K
Q2 22	$218.0K
Q3 22	$2M
Q4 22	$866.0K
Q1 23	$5M
Q2 23	$5M
Q3 23	$6M
Q4 23	$9M
Q1 24	$2M
Q2 24	$1M
Q3 24	$246.0K
Q4 24	$1M
Q1 25	$2M
Q2 25	$3M
Q3 25	$3M
Q4 25	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	+97.4%	+61.3%
Q2 22	+96.9%	+59.5%
Q3 22	+134.8%	+97.8%
Q4 22	+134.5%	+81.0%
Q1 23	+71.9%	+76.5%
Q2 23	+98.3%	+69.9%
Q3 23	+72.5%	+43.0%
Q4 23	+83.3%	+49.8%
Q1 24	+82.5%	+36.8%
Q2 24	+61.2%	+36.5%
Q3 24	+66.3%	+33.1%
Q4 24	+56.6%	+20.2%
Q1 25	+55.3%	+33.8%
Q2 25	+48.4%	+26.4%
Q3 25	+42.8%	+31.8%
Q4 25	+11.9%	+22.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$2M	10.9%
Q2 22	$3M	16.0%
Q3 22	$3M	15.8%
Q4 22	$3M	12.1%
Q1 23	$4M	15.3%
Q2 23	$5M	15.4%
Q3 23	$5M	15.2%
Q4 23	$5M	11.4%
Q1 24	$6M	14.0%
Q2 24	$8M	15.0%
Q3 24	$9M	14.6%
Q4 24	$9M	13.3%
Q1 25	$10M	14.6%
Q2 25	$12M	15.4%
Q3 25	$14M	17.4%
Q4 25	$11M	14.2%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 22	$5M	$18M
Q2 22	$7M	$20M
Q3 22	$8M	$25M
Q4 22	$10M	$26M
Q1 23	$11M	$30M
Q2 23	$12M	$32M
Q3 23	$12M	$33M
Q4 23	$14M	$36M
Q1 24	$13M	$40M
Q2 24	$18M	$41M
Q3 24	$17M	$43M
Q4 24	$15M	$48M
Q1 25	$16M	$55M
Q2 25	$18M	$56M
Q3 25	$18M	$59M
Q4 25	$19M	$58M

Revenue by Geography

Quarter	Outside the United States	United States
Q3 23	$3M	$32M
Q1 24	$4M	$40M
Q2 24	$6M	$48M
Q3 24	$6M	$52M
Q4 24	$8M	$60M
Q1 25	$9M	$60M
Q2 25	$10M	$70M
Q3 25	$9M	$74M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$284M	$0	$284M
Q2 22	$270M	$0	$270M
Q3 22	$249M	$0	$249M
Q4 22	$223M	$0	$223M
Q1 23	$182M	$0	$182M
Q2 23	$150M	$0	$150M
Q3 23	$288M	$0	$288M
Q4 23	$257M	$0	$257M
Q1 24	$226M	$0	$226M
Q2 24	$214M	$0	$214M
Q3 24	$197M	$0	$197M
Q4 24	$334M	$0	$334M
Q1 25	$316M	$0	$316M
Q2 25	$303M	$0	$303M
Q3 25	$294M	$0	$294M
Q4 25	$287M	$0	$287M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	44M	+0.7%	+24.8%
Q2 22	44M	+1.1%	+7.5%
Q3 22	45M	+0.7%	+5.3%
Q4 22	45M	+0.3%	+2.8%
Q1 23	45M	+0.7%	+2.8%
Q2 23	45M	+0.2%	+1.9%
Q3 23	48M	+7.0%	+8.2%
Q4 23	51M	+4.7%	+13.0%
Q1 24	51M	+0.8%	+13.2%
Q2 24	52M	+1.2%	+14.3%
Q3 24	52M	+0.8%	+7.7%
Q4 24	54M	+3.5%	+6.4%
Q1 25	55M	+2.0%	+7.7%
Q2 25	55M	+1.0%	+7.4%
Q3 25	56M	+0.5%	+7.1%
Q4 25	56M	0.0%	+3.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$1M	13
Q2 22	$1M	13
Q3 22	$2M	13
Q4 22	$55.6K	428
Q1 23	$57.0K	428
Q2 23	$77.3K	428
Q3 23	$82.0K	428
Q4 23	$69.6K	626
Q1 24	$71.1K	626
Q2 24	$85.2K	626
Q3 24	$93.2K	626
Q4 24	$90.3K	756
Q1 25	$91.5K	756
Q2 25	$104.7K	756
Q3 25	$110.2K	756
Q4 25	$86.0K	888

Revenue / Employee